SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,080 shares of the exchange traded fund’s stock after selling 359 shares during the period. Bank of New York Mellon Corp’s holdings in SPDR S&P Biotech ETF were worth $331,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Demars Financial Group LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $280,309,000. BlueCrest Capital Management Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $138,051,000. Bessemer Group Inc. lifted its position in shares of SPDR S&P Biotech ETF by 4.0% during the first quarter. Bessemer Group Inc. now owns 1,432,066 shares of the exchange traded fund’s stock worth $116,141,000 after purchasing an additional 55,232 shares in the last quarter. RA Capital Management L.P. acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $110,615,000. Finally, Employees Retirement System of Texas lifted its position in shares of SPDR S&P Biotech ETF by 33.6% during the fourth quarter. Employees Retirement System of Texas now owns 877,272 shares of the exchange traded fund’s stock worth $79,007,000 after purchasing an additional 220,400 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.0%

NYSEARCA XBI opened at $86.82 on Tuesday. The company’s fifty day simple moving average is $84.48 and its 200-day simple moving average is $84.19. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $105.47. The stock has a market cap of $4.70 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.